These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 18589358
1. Plasma DNA is more reliable than carcinoembryonic antigen for diagnosis of recurrent esophageal cancer. Banki F, Yacoub WN, Hagen JA, Mason RJ, Ayazi S, DeMeester SR, Lipham JC, Danenberg K, Danenberg P, DeMeester TR. J Am Coll Surg; 2008 Jul; 207(1):30-5. PubMed ID: 18589358 [Abstract] [Full Text] [Related]
2. Plasma DNA as a molecular marker for completeness of resection and recurrent disease in patients with esophageal cancer. Banki F, Mason RJ, Oh D, Hagen JA, DeMeester SR, Lipham JC, Tanaka K, Danenberg KD, Yacoub WN, Danenberg PV, DeMeester TR. Arch Surg; 2007 Jun; 142(6):533-8; discussion 538-9. PubMed ID: 17576889 [Abstract] [Full Text] [Related]
3. Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer. Nakashima S, Natsugoe S, Matsumoto M, Miyazono F, Nakajo A, Uchikura K, Tokuda K, Ishigami S, Baba M, Takao S, Aikou T. Surgery; 2003 Feb; 133(2):162-9. PubMed ID: 12605177 [Abstract] [Full Text] [Related]
4. Carcinoembryonic antigen messenger RNA expression in blood predicts recurrence in esophageal cancer. Setoyama T, Natsugoe S, Okumura H, Matsumoto M, Uchikado Y, Ishigami S, Owaki T, Takao S, Aikou T. Clin Cancer Res; 2006 Oct 15; 12(20 Pt 1):5972-7. PubMed ID: 17062668 [Abstract] [Full Text] [Related]
5. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer. Gaspar MJ, Diez M, Rodriguez A, Ratia T, Martin Duce A, Galvan M, Granell J, Coca C. Anticancer Res; 2003 Oct 15; 23(4):3427-32. PubMed ID: 12926084 [Abstract] [Full Text] [Related]
6. [Diagnostic application of detecting AgNOR in peripheral blood T lymphocyte in patients with esophageal carcinoma]. Wang JY, Rong TH, Liang YR, Long H, Chen QL, Ma GW. Ai Zheng; 2004 May 15; 23(5):577-80. PubMed ID: 15142458 [Abstract] [Full Text] [Related]
10. Detection and quantification of circulating tumor cells in patients with esophageal cancer by real-time polymerase chain reaction. Ito H, Kanda T, Nishimaki T, Sato H, Nakagawa S, Hatakeyama K. J Exp Clin Cancer Res; 2004 Sep 15; 23(3):455-64. PubMed ID: 15595636 [Abstract] [Full Text] [Related]
13. EIA versus RIA in detecting carcinoembryonic antigen level of patients with metastatic colorectal cancer. Wang WS, Lin JK, Lin TC, Chiou TJ, Liu JH, Yen CC, Chen WS, Jiang JK, Yang SH, Wang HS, Chen PM. Hepatogastroenterology; 2004 Sep 15; 51(55):136-41. PubMed ID: 15011849 [Abstract] [Full Text] [Related]
15. Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin. Chan AO, Chu KM, Lam SK, Cheung KL, Law S, Kwok KF, Wong WM, Yuen MF, Wong BC. Cancer; 2005 Aug 15; 104(4):740-6. PubMed ID: 15991243 [Abstract] [Full Text] [Related]
17. The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients. Mroczko B, Kozłowski M, Groblewska M, Łukaszewicz M, Nikliński J, Jelski W, Laudański J, Chyczewski L, Szmitkowski M. Clin Chim Acta; 2008 Mar 15; 389(1-2):61-6. PubMed ID: 18155162 [Abstract] [Full Text] [Related]